APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over-the-Counter Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Over-the-Counter Drugs Market Analysis and Forecast 2026-2032

26 December 2025194 pages

Choose your research edition.

Industry ResearchOver-the-Counter Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Over-the-Counter Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Over-the-Counter Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over-the-Counter Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Over-the-Counter Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Over-the-Counter Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Over-the-Counter Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Over-the-Counter Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Over-the-Counter Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Over-the-Counter Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Over-the-Counter Drugs include Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Sun Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Over-the-Counter Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Over-the-Counter Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Over-the-Counter Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Over-the-Counter Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Over-the-Counter Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Over-the-Counter Drugs revenue, projected growth trends, production technology, application and end-user industry.

Over-the-Counter Drugs Segment by Company

Teva Pharmaceutical Industries

Sanofi

Johnson & Johnson

Novartis

Merck

Pfizer

GlaxoSmithKline

Bayer

Sun Pharmaceutical Industries

Glenmark Pharmaceuticals

Cipla

Boehringer Ingelheim

Alkem Laboratories

Over-the-Counter Drugs Segment by Type

Cough, Cold and Flu Products

Weight Loss Products

Smoking Cession Aids

Dermatological Products

Sleep Aids

Vitamin & Mineral Supplements

Gastrointestinal Products

Ophthalmic Products

Analgesics & Pain Relievers

Other

Over-the-Counter Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Over-the-Counter Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-the-Counter Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over-the-Counter Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-the-Counter Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Over-the-Counter Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Over-the-Counter Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Over-the-Counter Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Over-the-Counter Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cough, Cold and Flu Products Major Player Table 3. Weight Loss Products Major Player Table 4. Smoking Cession Aids Major Player Table 5. Dermatological Products Major Player Table 6. Sleep Aids Major Player Table 7. Vitamin & Mineral Supplements Major Player Table 8. Gastrointestinal Products Major Player Table 9. Ophthalmic Products Major Player Table 10. Analgesics & Pain Relievers Major Player Table 11. Other Major Player Table 12. Global Over-the-Counter Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 13. Hospital Pharmacies Major Player Table 14. Online Pharmacies Major Player Table 15. Retail Pharmacies Major Player Table 16. Over-the-Counter Drugs Industry Trends Table 17. Over-the-Counter Drugs Industry Drivers Table 18. Over-the-Counter Drugs Industry Opportunities and Challenges Table 19. Over-the-Counter Drugs Industry Restraints Table 20. Global Over-the-Counter Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 21. Global Over-the-Counter Drugs Market Size by Region (2021-2026) & (US$ Million) Table 22. Global Over-the-Counter Drugs Market Share by Region (2021-2026) Table 23. Global Over-the-Counter Drugs Market Size by Region (2027-2032) & (US$ Million) Table 24. Global Over-the-Counter Drugs Market Share by Region (2027-2032) Table 25. Global Over-the-Counter Drugs Revenue by Players (US$ Million) & (2021-2026) Table 26. Global Over-the-Counter Drugs Revenue Market Share by Players (2021-2026) Table 27. Global Over-the-Counter Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 28. Global Over-the-Counter Drugs Key Players Headquarters & Area Served Table 29. Global Over-the-Counter Drugs Players, Product Type & Application Table 30. Global Over-the-Counter Drugs Players Establishment Date Table 31. Global Players Market Concentration Ratio (CR5 and HHI) Table 32. Global Over-the-Counter Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Over-the-Counter Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Over-the-Counter Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Over-the-Counter Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Over-the-Counter Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Over-the-Counter Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Over-the-Counter Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Over-the-Counter Drugs Revenue by Application (2021-2026) & (US$ Million) Table 40. Global Over-the-Counter Drugs Revenue by Application (2027-2032) & (US$ Million) Table 41. Global Over-the-Counter Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Over-the-Counter Drugs Revenue Market Share by Application (2027-2032) Table 43. Teva Pharmaceutical Industries Company Information Table 44. Teva Pharmaceutical Industries Business Overview Table 45. Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio Table 47. Teva Pharmaceutical Industries Recent Development Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Sanofi Over-the-Counter Drugs Product Portfolio Table 52. Sanofi Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Johnson & Johnson Over-the-Counter Drugs Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Novartis Over-the-Counter Drugs Product Portfolio Table 62. Novartis Recent Development Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Merck Over-the-Counter Drugs Product Portfolio Table 67. Merck Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Pfizer Over-the-Counter Drugs Product Portfolio Table 72. Pfizer Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. GlaxoSmithKline Over-the-Counter Drugs Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Bayer Over-the-Counter Drugs Product Portfolio Table 82. Bayer Recent Development Table 83. Sun Pharmaceutical Industries Company Information Table 84. Sun Pharmaceutical Industries Business Overview Table 85. Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio Table 87. Sun Pharmaceutical Industries Recent Development Table 88. Glenmark Pharmaceuticals Company Information Table 89. Glenmark Pharmaceuticals Business Overview Table 90. Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio Table 92. Glenmark Pharmaceuticals Recent Development Table 93. Cipla Company Information Table 94. Cipla Business Overview Table 95. Cipla Over-the-Counter Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Cipla Over-the-Counter Drugs Product Portfolio Table 97. Cipla Recent Development Table 98. Boehringer Ingelheim Company Information Table 99. Boehringer Ingelheim Business Overview Table 100. Boehringer Ingelheim Over-the-Counter Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio Table 102. Boehringer Ingelheim Recent Development Table 103. Alkem Laboratories Company Information Table 104. Alkem Laboratories Business Overview Table 105. Alkem Laboratories Over-the-Counter Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Alkem Laboratories Over-the-Counter Drugs Product Portfolio Table 107. Alkem Laboratories Recent Development Table 108. North America Over-the-Counter Drugs Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Over-the-Counter Drugs Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Over-the-Counter Drugs Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Over-the-Counter Drugs Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Over-the-Counter Drugs Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Over-the-Counter Drugs Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Over-the-Counter Drugs Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Over-the-Counter Drugs Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Over-the-Counter Drugs Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Over-the-Counter Drugs Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Over-the-Counter Drugs Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Over-the-Counter Drugs Revenue by Country (US$ Million) & (2027-2032) Table 122. China Over-the-Counter Drugs Revenue by Type (2021-2026) & (US$ Million) Table 123. China Over-the-Counter Drugs Revenue by Type (2027-2032) & (US$ Million) Table 124. China Over-the-Counter Drugs Revenue by Application (2021-2026) & (US$ Million) Table 125. China Over-the-Counter Drugs Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Over-the-Counter Drugs Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Over-the-Counter Drugs Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Over-the-Counter Drugs Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Over-the-Counter Drugs Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Over-the-Counter Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Over-the-Counter Drugs Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Over-the-Counter Drugs Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Over-the-Counter Drugs Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Over-the-Counter Drugs Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Over-the-Counter Drugs Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Over-the-Counter Drugs Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Over-the-Counter Drugs Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Over-the-Counter Drugs Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Over-the-Counter Drugs Image Figure 2. Global Over-the-Counter Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over-the-Counter Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cough, Cold and Flu Products Image Figure 5. Weight Loss Products Image Figure 6. Smoking Cession Aids Image Figure 7. Dermatological Products Image Figure 8. Sleep Aids Image Figure 9. Vitamin & Mineral Supplements Image Figure 10. Gastrointestinal Products Image Figure 11. Ophthalmic Products Image Figure 12. Analgesics & Pain Relievers Image Figure 13. Other Image Figure 14. Global Over-the-Counter Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Over-the-Counter Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 16. Hospital Pharmacies Image Figure 17. Online Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Global Over-the-Counter Drugs Market Size (US$ Million) & (2021-2032) Figure 20. Global Over-the-Counter Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Over-the-Counter Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 22. Global Over-the-Counter Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Over-the-Counter Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Over-the-Counter Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Over-the-Counter Drugs Revenue Market Share by Type (2021-2032) Figure 27. Global Over-the-Counter Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Over-the-Counter Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 29. Global Over-the-Counter Drugs Revenue Market Share by Application (2021-2032) Figure 30. North America Over-the-Counter Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. North America Over-the-Counter Drugs Revenue Share by Type (2021-2032) Figure 32. North America Over-the-Counter Drugs Revenue Share by Application (2021-2032) Figure 33. North America Over-the-Counter Drugs Revenue Share by Country (2021-2032) Figure 34. United States Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Canada Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Mexico Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Europe Over-the-Counter Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 38. Europe Over-the-Counter Drugs Revenue Share by Type (2021-2032) Figure 39. Europe Over-the-Counter Drugs Revenue Share by Application (2021-2032) Figure 40. Europe Over-the-Counter Drugs Revenue Share by Country (2021-2032) Figure 41. Germany Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. France Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. U.K. Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Italy Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Spain Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Russia Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Netherlands Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Nordic Countries Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. China Over-the-Counter Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. China Over-the-Counter Drugs Revenue Share by Type (2021-2032) Figure 51. China Over-the-Counter Drugs Revenue Share by Application (2021-2032) Figure 52. Asia Over-the-Counter Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 53. Asia Over-the-Counter Drugs Revenue Share by Type (2021-2032) Figure 54. Asia Over-the-Counter Drugs Revenue Share by Application (2021-2032) Figure 55. Asia Over-the-Counter Drugs Revenue Share by Region (2021-2032) Figure 56. Japan Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. South Korea Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. India Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Australia Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Taiwan Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Southeast Asia Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. SAMEA Over-the-Counter Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 63. SAMEA Over-the-Counter Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Over-the-Counter Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Over-the-Counter Drugs Revenue Share by Country (2021-2032) Figure 66. Brazil Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Argentina Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Chile Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Colombia Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Peru Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Saudi Arabia Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Israel Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. UAE Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Turkey Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Iran Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Egypt Over-the-Counter Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold and Flu Products
  • Weight Loss Products
  • Smoking Cession Aids
  • Dermatological Products
  • Sleep Aids
  • Vitamin & Mineral Supplements
  • Gastrointestinal Products
  • Ophthalmic Products
  • Analgesics & Pain Relievers
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Sun Pharmaceutical Industries
  • Glenmark Pharmaceuticals
  • Cipla
  • Boehringer Ingelheim
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Over-the-Counter Drugs Market by Type
  3. 1.2.1 Global Over-the-Counter Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cough, Cold and Flu Products
  5. 1.2.3 Weight Loss Products
  6. 1.2.4 Smoking Cession Aids
  7. 1.2.5 Dermatological Products
  8. 1.2.6 Sleep Aids
  9. 1.2.7 Vitamin & Mineral Supplements
  10. 1.2.8 Gastrointestinal Products
  11. 1.2.9 Ophthalmic Products
  12. 1.2.10 Analgesics & Pain Relievers
  13. 1.2.11 Other
  14. 1.3 Over-the-Counter Drugs Market by Application
  15. 1.3.1 Global Over-the-Counter Drugs Market Size by Application, 2021 VS 2025 VS 2032
  16. 1.3.2 Hospital Pharmacies
  17. 1.3.3 Online Pharmacies
  18. 1.3.4 Retail Pharmacies
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 Over-the-Counter Drugs Market Dynamics
  1. 2.1 Over-the-Counter Drugs Industry Trends
  2. 2.2 Over-the-Counter Drugs Industry Drivers
  3. 2.3 Over-the-Counter Drugs Industry Opportunities and Challenges
  4. 2.4 Over-the-Counter Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Over-the-Counter Drugs Market Perspective (2021-2032)
  2. 3.2 Global Over-the-Counter Drugs Growth Trends by Region
  3. 3.2.1 Global Over-the-Counter Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Over-the-Counter Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Over-the-Counter Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Over-the-Counter Drugs Revenue by Players
  2. 4.1.1 Global Over-the-Counter Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Over-the-Counter Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Over-the-Counter Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Over-the-Counter Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Over-the-Counter Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Over-the-Counter Drugs Players, Product Type & Application
  8. 4.5 Global Over-the-Counter Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Over-the-Counter Drugs Market CR5 and HHI
  11. 4.6.3 2025 Over-the-Counter Drugs Tier 1, Tier 2, and Tier 3
5 Over-the-Counter Drugs Market Size by Type
  1. 5.1 Global Over-the-Counter Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Over-the-Counter Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Over-the-Counter Drugs Revenue Market Share by Type (2021-2032)
6 Over-the-Counter Drugs Market Size by Application
  1. 6.1 Global Over-the-Counter Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Over-the-Counter Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Over-the-Counter Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries
  2. 7.1.1 Teva Pharmaceutical Industries Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Over-the-Counter Drugs Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson Over-the-Counter Drugs Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novartis Over-the-Counter Drugs Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck Over-the-Counter Drugs Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Over-the-Counter Drugs Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Over-the-Counter Drugs Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Over-the-Counter Drugs Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 Sun Pharmaceutical Industries
  50. 7.9.1 Sun Pharmaceutical Industries Company Information
  51. 7.9.2 Sun Pharmaceutical Industries Business Overview
  52. 7.9.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
  54. 7.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 7.10 Glenmark Pharmaceuticals
  56. 7.10.1 Glenmark Pharmaceuticals Company Information
  57. 7.10.2 Glenmark Pharmaceuticals Business Overview
  58. 7.10.3 Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio
  60. 7.10.5 Glenmark Pharmaceuticals Recent Developments
  61. 7.11 Cipla
  62. 7.11.1 Cipla Company Information
  63. 7.11.2 Cipla Business Overview
  64. 7.11.3 Cipla Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Cipla Over-the-Counter Drugs Product Portfolio
  66. 7.11.5 Cipla Recent Developments
  67. 7.12 Boehringer Ingelheim
  68. 7.12.1 Boehringer Ingelheim Company Information
  69. 7.12.2 Boehringer Ingelheim Business Overview
  70. 7.12.3 Boehringer Ingelheim Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio
  72. 7.12.5 Boehringer Ingelheim Recent Developments
  73. 7.13 Alkem Laboratories
  74. 7.13.1 Alkem Laboratories Company Information
  75. 7.13.2 Alkem Laboratories Business Overview
  76. 7.13.3 Alkem Laboratories Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Alkem Laboratories Over-the-Counter Drugs Product Portfolio
  78. 7.13.5 Alkem Laboratories Recent Developments
8 North America
  1. 8.1 North America Over-the-Counter Drugs Revenue (2021-2032)
  2. 8.2 North America Over-the-Counter Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Over-the-Counter Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Over-the-Counter Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Over-the-Counter Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Over-the-Counter Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Over-the-Counter Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Over-the-Counter Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Over-the-Counter Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Over-the-Counter Drugs Revenue by Country
  11. 8.6.1 North America Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Over-the-Counter Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Over-the-Counter Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Over-the-Counter Drugs Revenue (2021-2032)
  2. 9.2 Europe Over-the-Counter Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Over-the-Counter Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Over-the-Counter Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Over-the-Counter Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Over-the-Counter Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Over-the-Counter Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Over-the-Counter Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Over-the-Counter Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Over-the-Counter Drugs Revenue by Country
  11. 9.6.1 Europe Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Over-the-Counter Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Over-the-Counter Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Over-the-Counter Drugs Revenue (2021-2032)
  2. 10.2 China Over-the-Counter Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Over-the-Counter Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Over-the-Counter Drugs Revenue by Type (2027-2032)
  5. 10.3 China Over-the-Counter Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Over-the-Counter Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Over-the-Counter Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Over-the-Counter Drugs Revenue by Application (2027-2032)
  9. 10.5 China Over-the-Counter Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Over-the-Counter Drugs Revenue (2021-2032)
  2. 11.2 Asia Over-the-Counter Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Over-the-Counter Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Over-the-Counter Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Over-the-Counter Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Over-the-Counter Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Over-the-Counter Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Over-the-Counter Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Over-the-Counter Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Over-the-Counter Drugs Revenue by Country
  11. 11.6.1 Asia Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Over-the-Counter Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Over-the-Counter Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Over-the-Counter Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Over-the-Counter Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Over-the-Counter Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Over-the-Counter Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Over-the-Counter Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Over-the-Counter Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Over-the-Counter Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Over-the-Counter Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Over-the-Counter Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Over-the-Counter Drugs Revenue by Country
  11. 12.6.1 SAMEA Over-the-Counter Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Over-the-Counter Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Over-the-Counter Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst